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RNA interference (RNAi) is a conserved eukaryotic mechanism by which double-stranded RNA (dsRNA) triggers the sequence-specific
degradation of homologous mRNAs. Recent concerns have arisen in mammalian systems about off-target effects of RNAi, as well as an interferon
response. Most mammalian cells respond to long dsRNAs by inducing an antiviral response mediated by interferon that leads to general inhibition
of protein synthesis and nonspecific degradation of mRNAs. Moreover, recent reports demonstrate that under certain conditions, short interfering
RNAs (siRNAs, 21–25 bp) may activate the interferon system. Mouse oocytes and preimplantation embryos apparently lack this response, as
potent and specific inhibition of gene expression triggered by long dsRNA is observed in these cells. In the present study, we analyzed the global
pattern of gene expression by microarray analysis in transgenic mouse oocytes expressing long dsRNA and find no evidence of off-targeting. We
also report that genes involved in the interferon response pathway are not expressed in mouse oocytes, even after exposure for an extended period
of time to long dsRNA.
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RNA interference (RNAi) is a conserved post-transcription-
al gene silencing mechanism present in most eukaryotes
wherein double-stranded RNA (dsRNA) triggers the se-
quence-specific degradation of cognate mRNAs (Denli and
Hannon, 2003). We have developed a transgenic RNAi
approach to study gene function during oocyte development.
The approach is based on using the oocyte-specific Zp3
promoter to drive expression of a long hairpin dsRNA that
contains sequence complementary to the gene under investi-
gation. The transgene is carried in the male, who is mated to a
wild-type female, and transgenic female F1 offspring are used
as the source of oocytes; non-transgenic female littermates
serve as controls (Stein et al., 2003).
We validated this transgenic RNAi approach by targeting
Mos. RNAi transgenic oocytes recapitulate the Mos null
phenotype, i.e., failure to activate MAP kinase and arrest at0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: rschultz@sas.upenn.edu (R.M. Schultz).metaphase II, and a high frequency of spontaneous partheno-
genetic activation (Stein et al., 2003). This transgenic RNAi
approach has been extended to study the function of three other
genes (Ctcf, Msy2, basonuclin) in oocytes and early embryos
(Fedoriw et al., 2004; Yu et al., 2004; Ma et al., unpublished
results). For each gene studied, a specific phenotype consistent
with the target gene’s known or proposed function is observed.
An advantage of the transgenic RNAi approach when
compared to a conventional knockout approach, besides being
technically simpler, is that it usually generates a range of
expression. This epiallelic series, analogous to a hypomorphic
series of mutants, typically yields a range of informative
phenotypes that provide critical insights into gene function. For
example, the epiallelic series of transgenic Mos RNAi oocytes
reveals that only 10–15% of the maximal amount of MAP
kinase activity is required to maintain metaphase II arrest (Stein
et al., 2003).
Although RNAi is observed from yeast to humans,
mammalian cells possess another pathway that responds to
long dsRNA by inducing interferon (IFN) a and h expression
and activating two dsRNA-dependent enzymes, namely,
dsRNA-dependent protein kinase (PKR) and 2V, 5V oligoade-86 (2005) 464 – 471
www.e
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ylates in response to dsRNA and subsequently phosphorylates
its substrates, one of which is the a subunit of the eukaryotic
translation initiation factor 2 (eIF2a); this post-translational
modification leads to a general inhibition of protein synthesis.
OAS, on the other hand, undergoes a conformational change
upon binding dsRNA and becomes activated to convert ATP to
2V5V-linked oligoadenylates of different lengths (2–5A). These
2–5A bind and activate a latent ribonuclease, RNase L, that
catalyses the nonspecific degradation of cellular or viral RNAs
(Samuel, 2001). In addition, activation of PKR and RNase L is
linked to apoptosis (Tan and Katze, 1999; Zhou et al., 1997).
This antiviral pathway is known as the interferon response.
The mechanism of action of type I IFNs (a/h) involves
binding to cell surface specific receptors and activating the
JAK–STAT pathway (Samuel, 2001). This signaling cascade
leads to the activation of transcription of hundreds of genes,
named IFN-stimulated genes or ISG (Sarkar and Sen, 2004).
PKR, the OAS family, and RNase L are within these ISG and
both PKR and OAS are dually regulated, transcriptionally by
IFN a and h and post-translationally by binding to dsRNA
(Jacobs and Langland, 1996).
dsRNA by itself, even in the absence of IFN, can
transcriptionally activate several hundred of genes, collectively
named DSG (dsRNA-stimulated genes). Some of these DSGs
are also activated by IFN. Yet expression of other genes is
repressed by dsRNA. Thus, dsRNA is a potent and global
modulator of gene expression in mammalian cells (Sarkar and
Sen, 2004).
Unlike PKR and Rnase L that are encoded by single genes,
mouse OAS is a family of proteins encoded by 12 different
genes (Oas1a to 1h, Oas2, Oas3, and Oasl1 and l2) located in
a cluster on chromosome 5 (Eskildsen et al., 2002). While all
mouse OAS proteins bind dsRNA, only a few of them have
catalytic activity (OAS1A, OAS1G, OAS2, OAS3, and
OASL2) (Kakuta et al., 2002). The different isoforms have
different tissue distribution, with OAS1A, 1G, 2, L1, and L2
highly expressed in digestive and lymphoid organs and
OAS1C, D, E, and H highly expressed in the ovary (Kakuta
et al., 2002).
The antiviral response is likely missing in some mammalian
cell types because long dsRNA triggers sequence-specific
mRNA degradation in mouse oocytes and early embryos,
undifferentiated mouse embryonic stem cells, undifferentiated
mouse embryonal carcinoma cells, differentiated mouse neu-
roblastoma cells, human peripheral blood mononuclear cells,
rat hypothalamus, and muscle cells (Svoboda et al., 2000;
Wianny and Zernicka-Goetz, 2000; Yang et al., 2001; Billy et
al., 2001; Gan et al., 2002; Park et al., 2002; Bhargava et al.,
2004; Yi et al., 2003; Kong et al., 2004). The reason for the
absence of a nonspecific response in these cell types is
unknown.
The nonspecific effects caused by activating the IFN
pathway initially severely hampered applying RNAi in many
mammalian cell types. This problem was apparently circum-
vented by finding that short interfering RNAs (siRNAs), rather
than long dsRNA, effectively knock-down the amount oftranscript of a given gene without activating the IFN system
(Harborth et al., 2001; Yu et al., 2002). Recent reports,
however, suggest that siRNAs may also activate components
of the interferon system, thus potentially affecting gene
expression more broadly (Kim et al., 2004; Sledz et al.,
2003; Bridge et al., 2003). In addition, other recent studies
have drawn attention to the existence of off-target effects of
RNAi, i.e., silencing of non-targeted genes containing partial
sequence identity to the siRNA (Jackson et al., 2003;
Persengiev et al., 2004). Because these studies were performed
using siRNAs to trigger RNAi, it is not known whether similar
nonspecific effects are generated by long dsRNA. Furthermore,
it is not known if expressing dsRNA constitutively from a
transgene, rather than by transfection or viral infection, avoids
the nonspecific response.
Although we never observed any evidence of nonspecific
effects in transgenic oocytes for the genes studied to date, it
is possible that such effects were not detected by the
methods used. In the present study, we used microarray
analysis to compare the global pattern of gene expression in
wild-type oocytes and oocytes exposed for an extended
period of time to long dsRNA. Our results show that RNAi
is extremely specific in that no interferon response and no
off-target effects are detected. The likely basis for the lack
of an interferon-like response is that oocytes do not express
genes essential for this pathway, but do express inhibitory
forms of OAS.
Materials and methods
Animals
The female mice used in this study were the second and third generation
(F2, F3) from Mos RNAi transgenic founder male #H13 (B6SJLF1/J
background) obtained by mating to wild-type CF1 females (Stein et al.,
2003). Oocyte collection was performed as previously described (Schultz et al.,
1983). All animal experiments were approved by the Institutional Animal Use
and Care Committee and were consistent with National Institutes of Health
guidelines.
RNA isolation, Affymetrix oligonucleotide array hybridization, and
data analysis
Total RNA isolation, double amplification, and array hybridization were
performed as previously described (Zeng et al., 2004). Briefly, RNA was
prepared from 30 fully-grown oocytes isolated from individual mice by using
PicoPure RNA isolation kit (Arcturus, Mountain View, CA) according to the
manufacturer’s instructions. Four transgenic and four wild-type animals were
used to have 4 replicates per group for the microarray analysis. Probes for
microarray analysis were hybridized to the MOE430A mouse GeneChip
(Affymetrix, Santa Clara, CA). The hybridized arrays were scanned and raw
data extracted by using Microarray Analysis Suite 5.0 software (Affymetrix).
GeneSpring 6.2 software (Silicon Genetics, Redwood City, CA) was used to
analyze differential expression.
Quantitative real-time PCR
Total RNA was extracted from fully-grown oocytes from wild-type and
transgenic animals by using Absolutely RNA\ Microprep Kit (Stratagene, La
Jolla, CA) according to the manufacturer’s instructions. cDNAwas prepared by
reverse transcription of total RNA with Superscript II enzyme and random
hexamer primers. One to two oocyte equivalents of the resulting cDNA were
P. Stein et al. / Developmental Biology 286 (2005) 464–471466amplified using TaqMan probes and the ABI Prism Sequence Detection System
7000 (Applied Biosystems, Foster City, CA) according to the manufacturer’s
protocols. Three replicates were used for each real-time PCR reaction; a minus
RT and a minus template served as controls. Quantification was normalized to
the endogenous histone H2a or upstream binding factor (Ubf) within the log-
linear phase of the amplification curve obtained for each probe/primer using the
comparative CT method (ABI PRISM 7700 Sequence Detection System, User
Bulletin #2, Applied Biosystems, 1997). The TaqMan gene expression assays
used were: Mm00504077_m1 (Dia1 ), Mm00833353_mH (Gsta2 ),
Mm00446807_m1 (Ppp2r4 ), Mm00551075_m1 (8430411H09Rik ),
Mm00456972_m1 (Ubf), Mm00501974_s1 (histone H2a), Mm00440966_m1
(Pkr ), Mm00712008_m1 (Rnasel ) , Mm00836412_m1 (Oas1a ) ,
Mm00726868_s1 (Oas1g), Mm00652489_m1 (Oas1d), Mm00459649_m1
(Oas1c), Mm00460961_m1 (Oas2), Mm00653062_m1 (Oas1e). For Mos,
the custom TaqMan Gene Expression Assay used had the following primers
and probes: forward primer 5VGGGAACAGGTATGTCTGATGCA3V, reverseFig. 1. Analysis of differentially expressed genes in KD vs. WT oocytes. (A) One-w
depicts the ratio of normalized intensity (KD/WT) as a function of the mean intensity
are shown either in open circles (over-expressed) or solid black circles (under-exp
selected genes. Shown are histograms of quantitative RT-PCR results of five genes t
depicts quantification of results of three independent experiments, normalized using
results were obtained using either standard. The fold change was calculated using t
difference compared to a ratio of 1.0 (WT = KD) is significant; P < 0.05, one-wayprimer 5 VCACCGTGGTAAGTGGCTTTATACA3 V, probe 5 VFAM
CCGAGCCAAACCCTC3V.
Immunoblotting
Equal numbers of oocytes from transgenic and wild-type mice were
transferred to 0.5-ml microcentrifuge tubes containing 10 Al of double-
concentrated Laemmli sample buffer. The oocyte extracts were electrophor-
esed in a 10% polyacrylamide-sodium dodecyl sulfate (SDS) gel and
transferred to a PVDF membrane using semi-dry transfer. The membrane
was blocked overnight at 4-C with ECLi Advance Blocking Agent (2%
w/v) dissolved in Tris-buffered saline (TBS) containing 0.1% Tween 20
(TTBS). The membrane was then probed with mouse monoclonal antibody
B-10 against PKR (Santa Cruz Biotechnology Inc., Santa Cruz, CA) at a
1:100 dilution, followed by horseradish peroxidase-conjugated secondary
antibody (donkey anti-mouse IgG; Jackson ImmunoResearch, West Grove,ay ANOVA analysis for microarrays of all genes present on the chip. The graph
, both in logarithmic scales. The eight significant differentially expressed genes
ressed). The arrow indicates the Mos gene. (B) Real-time RT-PCR analysis of
hat are differentially expressed according to the microarray analysis. The graph
either histone H2a or upstream binding factor (Ubf) as internal control; similar
he comparative CT method. The data are expressed as the mean T SEM. *, the
ANOVA.
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diluted in blocking solution and incubated for 1 h at room temperature; the
membrane was washed four times in TTBS after each incubation. The
signal was developed using ECLi Advance Western Blotting System
(Amersham Biosciences, Piscataway, NY). NIH/3T3 whole cell lysates
(Santa Cruz Biotechnology Inc.) were used as positive control for the
presence of PKR.
Results and discussion
To assess if any off-target effects or an interferon response is
present in mouse oocytes as a result of RNAi, we analyzed the
transcriptome in oocytes exposed to long dsRNA. We chose the
Mos RNAi transgenic mouse oocyte as a model system. Mos is
a dormant maternal message – Mos mRNA accumulates but is
not translated during oocyte growth; translation starts following
resumption of meiosis (Gebauer and Richter, 1997) – and
hence targeting Mos mRNA should not affect the relative
abundance of any other transcript in the oocyte. Therefore, any
differences in transcript abundance between wild-type and Mos
RNAi transgenic oocytes must be due exclusively to the effects
of dsRNA.
We have generated two lines of transgenic Mos RNAi mice
that display different degrees of targeting endogenous Mos
mRNA (Stein et al., 2003). We chose to conduct the expression
profiling experiments with the line that displays the greatest
reduction in endogenous Mos mRNA because these oocytes
would presumably have the highest likelihood of exhibiting
non-specific effects, i.e., this line would have the highest
degree of expression of dsRNA and highest level of siRNAs
derived from the long hairpin Mos dsRNA.
Expression profiling of fully-grown, germinal vesicle (GV)-
intact oocytes from Mos RNAi transgenic female mice (Mos
knockdown; KD (Stein et al., 2003)) and from wild-type
littermates (WT) was performed using Affymetrix oligonucle-
otide GeneChips; 10,118 genes on the MOE430A chip (44.6%)
were detected, which is within the normal range for the ‘‘A’’
chip. Consistent with no widespread nonspecific targeting
effects, hierarchical clustering using all the genes detected
showed that all samples (WT and KD) cluster together (data not
shown). Furthermore, when one-way ANOVA analysis forTable 1
Description of the genes identified by ANOVA as differentially expressed in KD v
Common name Genbank Raw valueb Flagsc
WT KD WT
Dpp3; 4930 533O14Rik AK015959 43.48 5.80 A
Mos NM_020021 2320.65 604.80 P
Gsta2 NM_008182 150.25 70.20 P
Dia1 NM_029787 670.38 412.53 P
Ppp2r4 NM_138748 46.58 110.58 A
8430411 H09Rik BB532544 30.83 96.78 A
Zdhhc12 NM_025428 34.20 130.98 A
261020 0G18Rik AK009389 9.88 54.27 A
a The list is sorted by fold-change (ratio KD/WT) values.
b Raw intensity mean of the four replicates.
c Microarray Analysis Suite 5.0 presence calls. A=absent; P=present; P,A=prese
d Fold change in mean intensity in KD oocytes compared to WT.microarrays (http://lgsun.grc.nia.nih.gov/ANOVA/index.html,
default parameters) was performed to identify differentially
expressed genes, only eight genes were found to be signifi-
cantly different in KD oocytes vs. WT oocytes; four of them
are increased in KD compared to WT and four are decreased
(Fig. 1A and Table 1). As anticipated, Mos is among the four
under-expressed genes and has the highest signal intensity of
all eight genes. Note that except for Mos, the other seven genes
in the list exhibit low levels of expression. The other three
genes that are under-expressed in transgenic oocytes do not
share any sequence similarity with Mos or among themselves
nor do they belong to a common pathway. The same is true for
the four up-regulated genes.
We next performed quantitative real-time RT-PCR analysis
to validate the expression patterns of the differentially
expressed genes. We elected to test only those genes with at
least one present call in one of the eight samples (flag filter,
Microarray Analysis Suite 5.0, Affymetrix). Fig. 1B shows that
Mos was indeed the only differentially expressed transcript in
transgenic oocytes (10.2% of WT levels).
To assess if an interferon response was present in KD
oocytes, we searched for interferon-stimulated genes (ISG) in
our gene list, in particular within the up-regulated genes. None
of the eight genes that showed differential expression between
KD and WT oocytes are known ISGs. Similarly, none of the
genes that have been described as dsRNA-regulated in somatic
cells (DSG) showed differential expression between KD and
WT samples. In fact, when we searched for interferons and
their receptors in our data set, we found very low levels of
expression of all of them and no difference whatsoever
between WT and KD oocytes (data not shown). Riego et al.
(1995) reported the presence of IFN-alpha mRNA in mouse
eggs and early embryos and Truchet et al. (2004) suggested
that signaling by type I IFNs is functional in mouse oocytes.
Conversely, Zusman et al. (1984) concluded that preimplanta-
tion mouse embryos appear to be resistant for both the antiviral
and antiproliferative activities of IFN. Our results show that
long dsRNA does not induce IFN production in mouse oocytes.
In light of the aforementioned results, we analyzed the
expression profiles of the genes involved in the interferons. WT oocytesa
Ratiod
(KD/WT)
Description
KD
A 0.13 RIKEN full-length enriched library,
clone: 4930533O14
P 0.26 Moloney sarcoma oncogene
P,A 0.46 Glutathione S-transferase, alpha 2 (Yc2)
P 0.61 diaphorase 1 (NADH)
P,A 2.37 Protein phosphatase 2A, regulatory subunit B (PR53)
P,A 3.14 RIKEN cDNA 8430411H09 gene
A 3.83 Zinc finger, DHHC domain containing 12
A 5.50 RIKEN cDNA 2610200G18 gene
nt in some replicates, absent in others.
Table 2
Expression profiles of genes involved in the interferon response in KD and WT oocytes
Gene symbol Genbank Normalized valuea Raw valueb Flagsc Ratiod
(KD/WT)
WT KD WT KD WT KD
Oas1b BC012877 1.130 0.921 174.80 132.20 A M,A 0.76
Oas1c NM_033541 0.914 0.979 3114.00 3138.00 P P 1.01
Oas1d NM_133893 0.967 1.003 6447.00 6359.00 P P 0.99
Oas1e AB067531 0.963 1.022 5438.00 5432.00 P P 1.00
Oas1g BC018470 1.085 0.862 132.60 98.82 A A 0.75
Oas1h AB067530 1.057 1.034 1033.00 948.40 P P 0.92
Oas2 AB067535 0.974 0.929 38.42 34.50 A A 0.90
Oas3 AB067534 1.338 0.941 31.10 20.35 A A 0.65
Oasl1 AB067533 0.855 1.026 67.82 78.95 P,M,A P,A 1.16
Oasl2 BQ033138 0.629 1.024 8.18 10.43 A A 1.28
Prkre BE911144 0.623 0.496 10.48 6.95 A A 0.66
Prkr M93567 0.982 0.837 41.05 34.85 M,A P,M 0.85
Rnasel BB761884 0.994 1.162 13.48 14.95 A A 1.11
a Intensity mean of the four replicates.
b Raw intensity mean of the four replicates.
c Microarray Analysis Suite 5.0 presence calls. A=absent; P=present; M=marginal.
d Fold change in mean intensity in KD oocytes compared to WT.
e Gene symbol for Pkr.
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the OAS/RNase L arm of the pathway appears to be missing in
mouse oocytes. Both OAS isoforms that have catalytic activity
(Oas1g, Oas2, Oas3, and Oasl2) and Rnasel are absent
according to the microarray results. On the other hand, some ofFig. 2. Real-time RT-PCR of genes involved in the interferon response. Shown are re
and Mos in one representative experiment. Equal numbers of oocytes were collecte
Materials and methods. Real-time PCR was done with 1 oocyte equivalent and thrthe inactive isoforms (Oas1c, 1d, and 1e), which are believed
to act as dominant negatives (Yan et al., 2005), are expressed at
very high levels. Note that Oas1a and 1f are not represented on
the MOE430A chip. As for Pkr, the levels of expression are
very low as well, with one of the probe sets having an absental-time RT-PCR results of six different Oas isoforms, together with Pkr, Rnasel,
d from WT and KD oocytes and RNA isolation was performed as described in
ee replicates were used for each real-time PCR reaction.
Fig. 3. Immunoblot of PKR. Four hundred oocytes obtained from wild-type
(WT) or transgenic (KD) mice were resolved on a 10% SDS-PAGE gel and
probed with an anti-PKR antibody as described in Materials and methods; four
hundred oocytes contain ¨10 Ag of protein. As a positive control, different
amounts (0.1–10 Ag) of NIH-3T3 whole cell lysates were run in parallel.
ECLi DualVue Western Blotting Markers were used to determine molecular
weights (first lane).
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For all 12 genes analyzed, there was no statistical difference in
expression between WT and KD oocytes.
We validated the results of the microarray analysis by
quantitative real-time RT-PCR. We measured the levels of
representative transcripts, including Pkr, Rnasel, and in
particular Oas1a, which is an active OAS that is not
represented on the A chip. Fig. 2 shows the graphs from a
representative experiment for 8 different genes involved in theTable 3
Expression profiles of genes involved in the interferon response in oocytes and ear
Gene symbol Raw valuea
Ooc 1C 2C 8C Bl
Oas1b 208.10 191.80 97.23 17.75 35.8
Oas1c 3261.55 1987.40 798.13 10.25 5.2
Oas1d 7711.05 12001.95 763.15 34.80 7.9
Oas1e 6391.03 7255.10 763.15 49.55 41.6
Oas1f 893.68 625.13 587.73 254.18 357.0
Oas1g 145.95 95.67 120.23 54.98 123.2
Oas1h 1618.10 806.63 161.15 26.50 19.5
Oas2 34.33 26.60 28.53 64.83 34.3
Oas3 51.75 35.58 52.38 32.20 38.9
Oasl1 56.95 58.70 48.35 94.60 49.5
Oasl2 7.10 5.55 7.33 25.00 7.2
Prkr 42.32 44.43 51.98 57.55 27.5
Prkr 20.13 27.53 23.22 51.55 33.2
Rnasel 13.55 9.20 10.75 23.93 34.9
Rnasel 2.88 3.55 7.50 4.58 15.3
Rnasel 18.88 38.65 64.08 43.65 39.8
a Raw intensity mean of the four replicates.
b Microarray Analysis Suite 5.0 presence calls. A=absent; P=present; M=margin
c Oo: oocyte; 1C: 1-cell embryo; 2C: 2-cell embryo; 8C: 8-cell embryo; Bl: blasinterferon response; Mos levels were also measured as a
control. Oas1a, Oas1g, Oas2, Pkr, and Rnasel are absent or
present at extremely low levels, while Oas1c, 1d, and 1e are
abundantly expressed. Using the combined data from three
experiments and the DDCT method, we determined that there
was no significant difference in transcript levels between WT
and KD oocytes for any of the 8 genes tested. Therefore, real-
time RT-PCR experiments confirm the results obtained using
microarrays.
Of note, Yan et al. (2005) reported the presence of OAS1A
in mouse oocytes and showed that OAS1D directly interacts
with OAS1A and inhibits its activity. The authors generated
mice deficient in OAS1D and found that, although null females
display reduced fertility, their oocytes do not mount an
interferon response to dsRNA injection. This result indicates
that the high levels of OAS1C and OAS1E in oocytes are still
sufficient to prevent the action of OAS1A. Another possibility
is that because RNase L is absent or present at very low levels,
the OAS/RNase L arm of the pathway does not operate, even in
the absence of OAS1D.
Because mRNA levels do not always correlate with protein
levels, we proceeded to measure PKR protein levels by
immunoblotting (Fig. 3). Using NIH/3T3 whole cell lysates
as positive control, we demonstrated that mouse oocytes have
undetectable levels of PKR and that extended exposure to long
dsRNA does not increase them. We were unable to measure
RNase L protein levels, due to the lack of suitable antibodies.
That we did not observe any difference in abundance of cellular
mRNAs between WT and KD oocytes in the microarray data
set indicates the absence of an active RNase L enzyme. Taken
together, the results presented here indicate that the expression
of long dsRNA does not trigger an interferon response in
mouse oocytes.
We do not know when this antiviral response develops in
the embryo but based on expression profiling data (Zengly embryos
Present/absent callb Genbank
Oo 1C 2C 8C Bl
0 P,A A A A A BC012877
5 P P P A A NM_033541
2 P P P P,A A NM_133893
8 P P P A A AB067531
0 P P P P,M,A P BB147559
0 A A A A A BC018470
0 P P P A A AB067530
5 A P,A A A A AB067535
3 A A A A A AB067534
5 M,A A A A A AB067533
0 A A A M,A A BQ033138
7 P,M,A P,A P,A A A M93567
8 A A A M,A P,A BE911144
3 A A A A A BB761884
5 A A A A P BF714880
5 A A A A A BB551645
al.
tocyst.
P. Stein et al. / Developmental Biology 286 (2005) 464–471470et al., 2004), it is unlikely that a robust response initiates
prior to the blastocyst stage because the levels of expression
of the genes involved in the interferon response pathway do
not increase from the oocyte to the blastocyst stage (Table
3). Although PKR can be detected by Western blot in
blastocysts, albeit at very low levels (data not shown), RNAi
triggered by long dsRNA works efficiently in the early
embryo until the blastocyst stage (Svoboda et al., 2004;
Wianny and Zernicka-Goetz, 2000). RNAi also works
efficiently in ES cells, which are derived from the inner
cell mass of blastocysts (Yang et al., 2001). These data
indicate that the interferon response most likely becomes
active post-implantation.
There are a variety of factors that determine how a specific
cell type responds to dsRNA. These include the concentration
of dsRNA, the cellular repertoire of proteins involved in RNAi
and the IFN response, and the form of administering dsRNA.
Both off-target effects and induction of an interferon response
by siRNAs are concentration dependent (Kim et al., 2004;
Sledz et al., 2003; Jackson et al., 2003). We do not know what
the levels of dsRNA, and hence of siRNAs, are in these
transgenic oocytes. Nevertheless, when oocytes from another
RNAi transgenic mouse (Ctcf knockdown animals (Fedoriw et
al., 2004)) were subject to a similar approach using Affymetrix
oligonucleotide arrays the same result was obtained, namely,
the absence of the proteins involved in the interferon response
pathway (Wan and Bartolomei, personal communication).
Because Ctcf is not a dormant message, we could not look
for off-target effects in these oocytes. It is also not known
whether dsRNA expressed in the nucleus has the same
likelihood of producing off-target effects as dsRNA adminis-
tered in the cytoplasm, either by microinjection, transfection, or
viral infection. For example, liposomal transfection reagents
induce IFN synthesis and activate ISGs (Li et al., 1998).
Noteworthy, in numerous experiments where dsRNA was
microinjected into the cytoplasm of mouse oocytes or 1-cell
embryos we never observed any evidence of apoptosis, even
after culturing the embryos to the blastocyst stage (data not
shown).
Micro RNAs (miRNAs), single-stranded RNA molecules of
21–22 nt (Bartel, 2004), are produced from a hairpin precursor
by Dicer, which also initiates the RNAi pathway by cleaving
long dsRNA molecules to produce siRNAs. Although initial
studies characterized miRNAs as repressors of translation by
binding to the 3VUTR of protein-coding mRNAs, it is now
clear that both siRNAs and miRNAs can either repress
translation when they are mismatched to the target mRNA or
lead to mRNA cleavage, when perfectly matched (Bartel,
2004; Doench et al., 2003; Zeng et al., 2003). In the present
study, we assessed the global pattern of gene expression at the
transcript level, and therefore cannot exclude the possibility
that some off-target effects due to translation blockade by
siRNAs or miRNAs exist at the protein level. In fact,
nonspecific effects of siRNAs at the protein level have been
reported (Scacheri et al., 2004) and although protein and
mRNA levels generally correlated, the magnitude of the
changes was not always equal.Despite the fact that the search for off-targeting was
performed in only one RNAi transgenic mouse model (Mos
KD) and that we cannot rule out the possibility of nonspecific
effects at the protein level, we believe that it is unlikely that
these off-target effects exist in this transgenic RNAi approach.
First, oocytes expressing dsRNA to different genes have
phenotypes consistent with the proposed role of the targeted
gene. Second, H1foo knockdown mice exhibit no discernable
phenotype whatsoever, despite the absence of detectable
H1F00 protein (E. Adashi, personal communication). Last,
because we only used the Affymetrix A chip it is possible
that genes present on the B chip may be mis-regulated in
response to long dsRNA.
The results reported here provide further support that
transgenic RNAi is highly specific in mouse oocytes and
therefore is a robust and simple method to study gene function
during oocyte development.
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